Sharing for the community and eager to hear any thoughts!
Pharma Program and Alliance Management Executive | Public Speaker | Venture Fellow and Startup Advisor | AI & ML Enthusiast
What’s the hardest part about turning a potential biotech breakthrough into a real-world success? Most people assume it’s the science. But in reality, the difference between good and exceptional success lies in bridging the gaps between development, regulation, and commercialization silos into a truly unified strategy & operatioal plan. In my latest article for?Regulatory Affairs Professionals Society (RAPS), co-authored with Susan Carino, FRAPS, MBA, MS, PMP, RAC, SSM, DTM, we explore the?entire?biotech asset journey, from early development to market and beyond. It’s a comprehensive guide to understanding the process—and why regulatory project managers, with the right commercial mindset, are uniquely suited to excel in this space. A heartfelt thank you to the editorial team at Regulatory Focus?for their support in bringing this work to fruition. Check and it out and eager to hear your thoughts! #Biotech #LifecycleManagement #Innovation